Epidemiology and prevention of human papillomavirus and cervical cancer in sub‐Saharan Africa: a comprehensive review

Tropical Medicine and International Health - Tập 14 Số 10 - Trang 1287-1302 - 2009
Karly S. Louie1,2, José Eluf‐Neto3,2, Philippe Mayaud1
1Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
2Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Catalá d'Oncologia, Barcelona, Spain
3CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain

Tóm tắt

SummaryObjectives  To identify the gaps of knowledge and highlight the challenges and opportunities for controlling cervical cancer in sub‐Saharan Africa (SSA).Methods  A comprehensive review of peer‐reviewed literature to summarize the epidemiological data on human papillomavirus (HPV) and invasive cervical cancer (ICC) by HIV status, to review feasible and effective cervical screening strategies, and to identify barriers in the introduction of HPV vaccination in SSA.Results  ICC incidence in SSA is one of the highest in the world with an age‐standardized incidence rate of 31.0 per 100 000 women. The prevalence of HPV16/18, the two vaccine preventable‐types, among women with ICC, does not appear to differ by HIV status on a small case series. However, there are limited data on the role of HIV in the natural history of HPV infection in SSA. Cervical screening coverage ranges from 2.0% to 20.2% in urban areas and 0.4% to 14.0% in rural areas. There are few large scale initiatives to introduce population‐based screening using cytology, visual inspection or HPV testing. Only one vaccine safety and immunogenicity study is being conducted in Senegal and Tanzania. Few data are available on vaccine acceptability, health systems preparedness and vaccine cost‐effectiveness and long‐term impact.Conclusions  Additional data are needed to strengthen ICC as a public health priority to introduce, implement and sustain effective cervical cancer control in Africa.

Từ khóa


Tài liệu tham khảo

ACOG Practice Bulletin, 2005, Clinical management guidelines for obstetrician‐gynecologists. Number 61, April 2005. Human papillomavirus, Obstetrics and Gynecology, 105, 905

10.1093/oxfordjournals.aje.a010165

10.1093/jnci/djh192

Batson A, 2006, Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries, Vaccine, 24, S3/219

10.1002/jmv.20817

10.1016/j.ajog.2006.12.031

10.1136/jcp.55.4.244

Brown A, 2001, Sexual relations among young people in developing countries: evidence from WHO case studies

10.1056/NEJMoa011688

10.1016/S0968-8080(06)28250-8

10.1097/01.aids.0000253361.63578.14

10.1093/jnci/dji072

Curado M, 2007, Cancer Incidence in Five Continents

De Sanjose S, 2009, Worldwide HPV genotype distribution in 10,365 cases of cervical cancer

10.1002/ijc.23045

10.1002/cncr.10381

10.1016/j.vaccine.2006.05.121

10.1038/sj.bjc.6603252

10.1136/bmj.a1754

Ferlay J, 2004, GLOBOCAN 2002 cancer incidence. Mortality and prevalence worldwide

10.1016/j.vaccine.2008.05.041

10.1056/NEJMsa044278

10.1016/j.vaccine.2008.04.053

10.1016/j.vaccine.2008.05.002

10.1093/jnci/djj010

10.1097/00002030-199812000-00007

10.1097/00126334-200408010-00013

HPV Information Centre, 2009, Human papillomavirus and related cancers 2009

IARC Screening Group(2009)Cervical Cancer Screening Activities Directory (CxCaScreen): Research Projects/Programmes(http://screening.iarc.fr/activ/activity.php?lang=1). IARC Screening Group. 2009. Accessed 1 July 2009.

10.1067/mob.2002.119776

Kane MA, 2006, Chapter 15: HPV vaccine use in the developing world, Vaccine, 24, S3/132

10.1016/S0968-8080(08)32403-3

10.1093/jnci/dji187

10.1002/ijc.22947

Kuhn L, 2009, Screen‐and‐treat using HPV testing is highly effective among HIV‐infected women

Lehtinen M, 2006, Chapter 28: Studies to assess the long‐term efficacy and effectiveness of HPV vaccination in developed and developing countries, Vaccine, 24, S3/233

Levin C, 2008, Cost‐Effectiveness of Cerivcal Cancer Prevention in China

10.1086/322856

10.1038/sj.bjc.6604974

10.1136/sti.77.4.248

10.1097/00002030-200204120-00014

10.1016/j.vaccine.2006.06.018

Moscicki AB, 2009, Safety and Immunogenicity of Gardasil in HIV‐infected Children

10.1111/j.1471-0528.2009.02122.x

10.1097/00002030-199902250-00019

10.1016/j.vaccine.2006.05.120

Parkin DM, 2006, Chapter 2: The burden of HPV‐related cancers, Vaccine, 24, S3/11

10.1016/S1470-2045(08)70175-X

PATH, 2009, Cervical Cancer Prevention initiatives at PATH

10.1016/S1470-2045(08)70210-9

10.1038/sj.bjc.6603737

10.1016/j.vaccine.2008.05.005

Sankaranarayanan R, 2001, Effective screening programmes for cervical cancer in low‐and middle‐income developing countries, Bulletin of the World Health Organization, 79, 954

10.1016/S0140-6736(07)61195-7

10.1056/NEJMoa0808516

10.1016/j.virol.2005.04.002

10.1016/j.vaccine.2008.06.002

10.1086/375783

10.1002/ijc.23630

10.1093/jnci/95.14.1062

10.1056/NEJM199711063371903

UNAIDS, 2008, Report on the Global AIDS Epidemic, December 2008

WHO, 2002, World Health Survey 2001/2002

Thông tin
Thông tin xuất bản

Tropical Medicine and International Health

Tập 14 Số 10

1287-1302

Thông tin tác giả